Here we demonstrated that CH12 had a significant growth-suppression effect on EGFRvIII+HER2+ breast cancers in vitro and in vivo (Figure 3A and 3B) at least partially through inhibiting the phosphorylation of EGFR, AKT and STAT3 (Figure 3C and 3D). Here, ERBB2 is linked to breast carcinoma.